Mirion Technologies (NYSE:MIR) Upgraded at Melius Research

Melius Research upgraded shares of Mirion Technologies (NYSE:MIR) to a strong-buy rating in a research note published on Monday morning,Zacks.com reports.

Other equities analysts also recently issued reports about the stock. Morgan Stanley lowered their target price on shares of Mirion Technologies from $29.00 to $27.00 and set an “equal weight” rating on the stock in a research report on Wednesday, March 11th. JPMorgan Chase & Co. reduced their price target on Mirion Technologies from $33.00 to $30.00 and set an “overweight” rating for the company in a research report on Monday, March 9th. Evercore began coverage on Mirion Technologies in a research note on Tuesday, November 25th. They set an “outperform” rating and a $29.00 price target for the company. The Goldman Sachs Group lowered their price objective on Mirion Technologies from $33.00 to $29.00 and set a “buy” rating on the stock in a report on Thursday, February 12th. Finally, Citigroup cut their price objective on Mirion Technologies from $32.00 to $29.00 and set a “buy” rating on the stock in a research note on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $27.63.

Mirion Technologies Stock Performance

MIR stock opened at $18.83 on Monday. The firm has a 50 day moving average of $22.53 and a two-hundred day moving average of $23.89. Mirion Technologies has a 12 month low of $12.00 and a 12 month high of $30.28. The company has a market capitalization of $4.72 billion, a price-to-earnings ratio of 171.23 and a beta of 0.99. The company has a quick ratio of 2.34, a current ratio of 2.83 and a debt-to-equity ratio of 0.62.

Mirion Technologies (NYSE:MIR) last released its quarterly earnings results on Tuesday, February 10th. The company reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.01). Mirion Technologies had a net margin of 3.11% and a return on equity of 6.97%. The business had revenue of $277.40 million for the quarter, compared to the consensus estimate of $281.17 million. During the same quarter in the prior year, the business posted $0.17 EPS. The firm’s revenue for the quarter was up 9.1% compared to the same quarter last year. Mirion Technologies has set its FY 2026 guidance at 0.500-0.570 EPS. As a group, equities analysts anticipate that Mirion Technologies will post 0.39 EPS for the current fiscal year.

Institutional Trading of Mirion Technologies

Hedge funds have recently modified their holdings of the company. Thrivent Financial for Lutherans bought a new stake in Mirion Technologies in the 3rd quarter valued at $4,182,000. JPMorgan Chase & Co. raised its stake in shares of Mirion Technologies by 187.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 825,269 shares of the company’s stock valued at $17,768,000 after buying an additional 537,900 shares in the last quarter. Rhumbline Advisers lifted its holdings in shares of Mirion Technologies by 91.1% during the 3rd quarter. Rhumbline Advisers now owns 608,834 shares of the company’s stock worth $14,161,000 after acquiring an additional 290,232 shares during the period. Louisiana State Employees Retirement System bought a new position in shares of Mirion Technologies during the 3rd quarter worth about $2,438,000. Finally, New York State Teachers Retirement System acquired a new stake in shares of Mirion Technologies during the 3rd quarter valued at about $1,269,000. Institutional investors own 78.51% of the company’s stock.

Mirion Technologies Company Profile

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.